Pharmaceutical Technology1h
ACC 25: tirzepatide influences clinical trajectory of patients with HFpEF and obesity
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.
Prices of 80 meds revised, diabetes drugs to cost less
KOLKATA: The National Pharmaceutical Pricing Authority (NPPA) revised prices for 80 medicines from April 1, with major cuts ...
Anti-diabetic drugs cheaper, heart medicine to cost more
Kolkata: The National Pharmaceutical Pricing Authority (NPPA), in an order dated March 27, changed the prices of 80 medicines ...
Pharmabiz4d
NPPA fixes prices of 80 new drugs
The National Pharmaceutical Pricing Authority (NPPA) has fixed prices of 80 new drugs including anti-diabetes, anti-hypertension, pain relief formulations from major pharmaceutical companies, in its ...
Inventiva reports its 2024 full year results and provides a business update
Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31, 2024 First ...
Chronic Kidney Disease Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...